-
公开(公告)号:US20220010291A1
公开(公告)日:2022-01-13
申请号:US17293800
申请日:2019-11-11
Applicant: DSM IP ASSETS B.V.
Abstract: The present invention is related to an improved process for production of vitamin B2 using a genetically engineered host cell comprising a heterologous enzyme with pyridoxal phosphatase activity. Using said modified host cell, the yield of riboflavin production could be increased by at least about 5%.